Cargando…

Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study

BACKGROUND: Our aim was to study the prevalence of self-reported hypoglycaemic sensations and its association with mortality in patients with type 2 diabetes (T2D) treated with insulin in usual care. METHODS: Demographics, clinical characteristics and mortality data were obtained from 1667 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauh, Simone P, Rutters, Femke, Thorsted, Brian L, Wolden, Michael L, Nijpels, Giel, van der Heijden, Amber A W A, Walraven, Iris, Elders, Petra J, Heymans, Martijn W, Dekker, Jacqueline M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030618/
https://www.ncbi.nlm.nih.gov/pubmed/27645557
http://dx.doi.org/10.1136/bmjopen-2016-012793
_version_ 1782454709919940608
author Rauh, Simone P
Rutters, Femke
Thorsted, Brian L
Wolden, Michael L
Nijpels, Giel
van der Heijden, Amber A W A
Walraven, Iris
Elders, Petra J
Heymans, Martijn W
Dekker, Jacqueline M
author_facet Rauh, Simone P
Rutters, Femke
Thorsted, Brian L
Wolden, Michael L
Nijpels, Giel
van der Heijden, Amber A W A
Walraven, Iris
Elders, Petra J
Heymans, Martijn W
Dekker, Jacqueline M
author_sort Rauh, Simone P
collection PubMed
description BACKGROUND: Our aim was to study the prevalence of self-reported hypoglycaemic sensations and its association with mortality in patients with type 2 diabetes (T2D) treated with insulin in usual care. METHODS: Demographics, clinical characteristics and mortality data were obtained from 1667 patients with T2D treated with insulin in the Hoorn Diabetes Care System Cohort (DCS), a prospective cohort study using clinical care data. Self-reported hypoglycaemic sensations were defined as either mild: events not requiring help; or severe: events requiring help from others (either medical assistance or assistance of others). The association between hypoglycaemic sensations and mortality was analysed using logistic regression analysis. RESULTS: At baseline, 981 patients (59%) reported no hypoglycaemic sensations in the past year, 612 (37%) reported only mild sensations and 74 (4%) reported severe hypoglycaemic sensations. During a median follow-up of 1.9 years, 98 patients (5.9%) died. Reporting only mild hypoglycaemic sensations was associated with a lower mortality risk (OR 0.48, 95% CI 0.28 to 0.80), while reporting severe sensations was not significantly associated with mortality (OR 0.76, 95% CI 0.33 to 1.80), compared with reporting no hypoglycaemic sensations, and adjusting for demographic and clinical characteristics. Sensitivity analyses showed an OR of 1.38 (95% CI 0.31 to 6.11) for patients reporting severe hypoglycaemic sensations requiring medical assistance. CONCLUSIONS: Self-reported hypoglycaemic sensations are highly prevalent in our insulin-treated T2D population. Patients reporting hypoglycaemic sensations not requiring medical assistance did not have an increased risk of mortality, suggesting that these sensations are not an indicator of increased short-term mortality risk in patients with T2D.
format Online
Article
Text
id pubmed-5030618
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50306182016-10-04 Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study Rauh, Simone P Rutters, Femke Thorsted, Brian L Wolden, Michael L Nijpels, Giel van der Heijden, Amber A W A Walraven, Iris Elders, Petra J Heymans, Martijn W Dekker, Jacqueline M BMJ Open Diabetes and Endocrinology BACKGROUND: Our aim was to study the prevalence of self-reported hypoglycaemic sensations and its association with mortality in patients with type 2 diabetes (T2D) treated with insulin in usual care. METHODS: Demographics, clinical characteristics and mortality data were obtained from 1667 patients with T2D treated with insulin in the Hoorn Diabetes Care System Cohort (DCS), a prospective cohort study using clinical care data. Self-reported hypoglycaemic sensations were defined as either mild: events not requiring help; or severe: events requiring help from others (either medical assistance or assistance of others). The association between hypoglycaemic sensations and mortality was analysed using logistic regression analysis. RESULTS: At baseline, 981 patients (59%) reported no hypoglycaemic sensations in the past year, 612 (37%) reported only mild sensations and 74 (4%) reported severe hypoglycaemic sensations. During a median follow-up of 1.9 years, 98 patients (5.9%) died. Reporting only mild hypoglycaemic sensations was associated with a lower mortality risk (OR 0.48, 95% CI 0.28 to 0.80), while reporting severe sensations was not significantly associated with mortality (OR 0.76, 95% CI 0.33 to 1.80), compared with reporting no hypoglycaemic sensations, and adjusting for demographic and clinical characteristics. Sensitivity analyses showed an OR of 1.38 (95% CI 0.31 to 6.11) for patients reporting severe hypoglycaemic sensations requiring medical assistance. CONCLUSIONS: Self-reported hypoglycaemic sensations are highly prevalent in our insulin-treated T2D population. Patients reporting hypoglycaemic sensations not requiring medical assistance did not have an increased risk of mortality, suggesting that these sensations are not an indicator of increased short-term mortality risk in patients with T2D. BMJ Publishing Group 2016-09-19 /pmc/articles/PMC5030618/ /pubmed/27645557 http://dx.doi.org/10.1136/bmjopen-2016-012793 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Diabetes and Endocrinology
Rauh, Simone P
Rutters, Femke
Thorsted, Brian L
Wolden, Michael L
Nijpels, Giel
van der Heijden, Amber A W A
Walraven, Iris
Elders, Petra J
Heymans, Martijn W
Dekker, Jacqueline M
Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title_full Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title_fullStr Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title_full_unstemmed Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title_short Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study
title_sort self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the hoorn diabetes care system cohort, the netherlands: a prospective cohort study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030618/
https://www.ncbi.nlm.nih.gov/pubmed/27645557
http://dx.doi.org/10.1136/bmjopen-2016-012793
work_keys_str_mv AT rauhsimonep selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT ruttersfemke selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT thorstedbrianl selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT woldenmichaell selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT nijpelsgiel selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT vanderheijdenamberawa selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT walraveniris selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT elderspetraj selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT heymansmartijnw selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy
AT dekkerjacquelinem selfreportedhypoglycaemiainpatientswithtype2diabetestreatedwithinsulininthehoorndiabetescaresystemcohortthenetherlandsaprospectivecohortstudy